Everything you need to know about NICE’s decisions on ‘game-changing’ Alzheimer’s drugs
In August and October 2024, the National Institute for Health and Care Excellence issued a decision not to recommend two new drugs for Alzheimer’s disease that experts had previously welcomed for their disease-modifying effects. We explain the reasons behind their decisions.…